Prognostic value of cardiopulmonary exercise testing in a European cohort with cardiovascular risk factors absent of a cardiovascular disease diagnosis.

[1]  W. Masson,et al.  Prognostic role of cardiopulmonary exercise testing in pulmonary hypertension: a systematic review and meta-analysis. , 2022, Advances in respiratory medicine.

[2]  R. Arena,et al.  The V˙E/V˙co2 Slope During Maximal Treadmill Cardiopulmonary Exercise Testing , 2021, Journal of cardiopulmonary rehabilitation and prevention.

[3]  M. Guazzi,et al.  Exercise chronotropic incompetence phenotypes the level of cardiovascular risk and exercise gas exchange impairment in the general population. An analysis of the Euro-EX prevention trial , 2020, European journal of preventive cardiology.

[4]  R. Arena,et al.  Exercise Intolerance in Patients With Heart Failure: JACC State-of-the-Art Review. , 2019, Journal of the American College of Cardiology.

[5]  R. Arena,et al.  Prevalence and characterization of exercise oscillatory ventilation in apparently healthy individuals at variable risk for cardiovascular disease: A subanalysis of the EURO-EX trial , 2016, European journal of preventive cardiology.

[6]  Sally J. Singh,et al.  Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement , 2016, European Respiratory Journal.

[7]  R. Arena,et al.  EACPR/AHA Joint Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. , 2012, European heart journal.

[8]  Ross Arena,et al.  Cardiopulmonary exercise testing in the clinical evaluation of patients with heart and lung disease. , 2011, Circulation.